FDA Clearance Tracker · P240009-S006
Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Nov 4, 2026
Approved
Time to decision
401 days
Received Sep 29, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P240009-S006
- Device name
- Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection
- Applicant
- Contego Medical, Inc.
- Applicant location
- Raleigh, NC
- Received
- Sep 29, 2025
- Decided
- Nov 4, 2026
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P240009
Device type
- Device type
- Stent, carotid (NIM)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
The Neuroguard IEP Direct 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection used in conjunction with the Neuroguard IEP Embolic Protection System is indicated for improving carotid luminal diameter in subjects at high risk for adverse events from carotid endarterectomy who require carotid revascularization and meet the criteria outlined below: Patients with = 50% symptomatic stenosis of the internal carotid artery (ICA) or common carotid artery (CCA) as determined by angiography, CTA, or duplex ultrasound or patients with = 70% asymptomatic stenosis of the internal carotid artery (ICA) or common carotid artery (CCA) as determined by angiography, CTA, or duplex ultrasound Patients with a reference vessel diameter of 4.0 - 8.0 mm At least 5 cm of atherosclerosis free space in the ipsilateral common carotid artery between the sheath insertion site and the proximal edge of the target lesion. This device is also indicated for post-dilation of the stent component with simultaneous capture and removal of embolic material.
Source documents
Other decisions for Contego Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260600 · Decided Nov 4, 2026 · 253 days after receipt
Device type: Temporary Carotid Catheter For Embolic Capture (NTE) · Cardiology
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.